These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 16995466)
21. Is an elderly recipient a risk for living donor adult liver transplantation? Suehiro T; Shimada M; Kishikawa K; Shimura T; Soejima Y; Yoshizumi T; Hashimoto K; Mochida Y; Maehara Y; Kuwano H Hepatogastroenterology; 2008; 55(82-83):653-6. PubMed ID: 18613426 [TBL] [Abstract][Full Text] [Related]
22. The impact of donor variables on the outcome of orthotopic liver transplantation for hepatitis C. Yagci G; Fernandez LA; Knechtle SJ; D'Alessandro AM; Chin LT; Musat AI; Lucey MR; Said A; Pirsch JD; Leverson G; Kalayoglu M Transplant Proc; 2008; 40(1):219-23. PubMed ID: 18261591 [TBL] [Abstract][Full Text] [Related]
23. Factors affecting postoperative hyperbilirubinemia in the donor after living donor liver transplantation. Kamo N; Kaido T; Mori A; Hatano E; Takada Y; Egawa H; Uemoto S Hepatogastroenterology; 2009; 56(91-92):840-3. PubMed ID: 19621713 [TBL] [Abstract][Full Text] [Related]
24. Early changes of graft function, cytokines and superoxide dismutase serum levels after donor liver denervation and Kupffer cell depletion in a rat-to-rat liver transplantation model. Zhu H; Marco C; Gianfranco F Hepatobiliary Pancreat Dis Int; 2009 Apr; 8(2):152-6. PubMed ID: 19357028 [TBL] [Abstract][Full Text] [Related]
25. Donor safety and remnant liver volume in living donor liver transplantation. Taner CB; Dayangac M; Akin B; Balci D; Uraz S; Duran C; Killi R; Ayanoglu O; Yuzer Y; Tokat Y Liver Transpl; 2008 Aug; 14(8):1174-9. PubMed ID: 18668669 [TBL] [Abstract][Full Text] [Related]
26. Late onset of tacrolimus-related posterior leukoencephalopathy after living donor liver transplantation. Frühauf NR; Koeppen Dagger S; Saner FH; Egelhof Dagger T; Stavrou G; Nadalin S; Broelsch CE Liver Transpl; 2003 Sep; 9(9):983-5. PubMed ID: 12942462 [TBL] [Abstract][Full Text] [Related]
27. Comparison of the tolerance of hepatic ischemia/reperfusion injury in living donors: macrosteatosis versus microsteatosis. Han S; Kim G; Lee SK; Kwon CH; Gwak M; Lee S; Ha S; Park CK; Ko JS; Joh J Liver Transpl; 2014 Jul; 20(7):775-83. PubMed ID: 24687802 [TBL] [Abstract][Full Text] [Related]
28. Restoration of liver mass after partial hepatectomy--implications for living donor liver transplantation. Ibirogba SB; Spearman CW; Mall A; Shepherd E; Lotz Z; Tyler M; Kahn D S Afr J Surg; 2005 Aug; 43(3):70-2. PubMed ID: 16180390 [TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetics of tacrolimus in living donor liver transplant and deceased donor liver transplant recipients. Jain A; Venkataramanan R; Sharma R; Kwong T; Orloff M; Abt P; Kashyap R; Tsoulfas G; Batzold P; Williamson M; Bozorgzadeh A Transplantation; 2008 Feb; 85(4):554-60. PubMed ID: 18347534 [TBL] [Abstract][Full Text] [Related]
30. Evaluation of pre- and posttransplantation serum interferon-gamma and soluble CD30 for predicting liver allograft rejection. Kim KH; Oh EJ; Jung ES; Park YJ; Choi JY; Kim DG; Lee KY; Kang CS Transplant Proc; 2006 Jun; 38(5):1429-31. PubMed ID: 16797323 [TBL] [Abstract][Full Text] [Related]
31. [Adult-to-adult living donor liver transplantation in treating acute liver failure using extended right lobe graft]. He XS; Zhu XF; Hu AB; Wang DP; Ma Y; Wang GD; Ju WQ; Wu LW; Tai Q; Huang JF Zhonghua Wai Ke Za Zhi; 2007 Mar; 45(5):309-12. PubMed ID: 17535707 [TBL] [Abstract][Full Text] [Related]
32. Prognostic values of serum cystatin C and beta2 microglobulin, urinary beta2 microglobulin and N-acetyl-beta-D-glucosaminidase in early acute renal failure after liver transplantation. Hei ZQ; Li XY; Shen N; Pang HY; Zhou SL; Guan JQ Chin Med J (Engl); 2008 Jul; 121(14):1251-6. PubMed ID: 18713542 [TBL] [Abstract][Full Text] [Related]
34. Clinical relevance and prevalence of polymorphisms in CYP3A5 and MDR1 genes that encode tacrolimus biotransformation enzymes in liver transplant recipients. Barrera-Pulido L; Aguilera-García I; Docobo-Pérez F; Alamo-Martínez JM; Pareja-Ciuró F; Nuñez-Roldán A; Gómez-Bravo MA; Bernardos-Rodríguez A Transplant Proc; 2008 Nov; 40(9):2949-51. PubMed ID: 19010156 [TBL] [Abstract][Full Text] [Related]
35. The impact of donor age on the outcome of adult living donor liver transplantation. Iwamoto T; Yagi T; Umeda Y; Sato D; Matsukawa H; Matsuda H; Shinoura S; Sadamori H; Mizuno K; Yoshida R; Tanaka N Transplantation; 2008 May; 85(9):1240-5. PubMed ID: 18475178 [TBL] [Abstract][Full Text] [Related]
36. Major influence of liver function itself but not of immunosuppression determines glucose tolerance after living-donor liver transplantation. Stockmann M; Konrad T; Nolting S; Hünerbein D; Wernecke KD; Döbling H; Steinmüller T; Neuhaus P Liver Transpl; 2006 Apr; 12(4):535-43. PubMed ID: 16496277 [TBL] [Abstract][Full Text] [Related]
38. Expression of iNOS in early injury in a rat model of small-for-size liver transplantation. Jiang WW; Kong LB; Li GQ; Wang XH Hepatobiliary Pancreat Dis Int; 2009 Apr; 8(2):146-51. PubMed ID: 19357027 [TBL] [Abstract][Full Text] [Related]
39. Thrombopoietin levels and peripheral platelet counts following living related donor liver transplantation. Tsukahara A; Sato Y; Yamamoto S; Suzuki S; Nakatsuka H; Watanabe T; Kameyama H; Hatakeyama K Hepatogastroenterology; 2003; 50(49):227-30. PubMed ID: 12630028 [TBL] [Abstract][Full Text] [Related]
40. Graft weight/recipient weight ratio: how well does it predict outcome after partial liver transplants? Hill MJ; Hughes M; Jie T; Cohen M; Lake J; Payne WD; Humar A Liver Transpl; 2009 Sep; 15(9):1056-62. PubMed ID: 19718640 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]